Medikanuclear S.A. (Ecuador)

Main Activities: Retail Trade

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores

Full name: Medikanuclear S.A.

Profile Updated: February 11, 2025

Medikanuclear S.A. is an enterprise located in Ecuador, with the main office in Quito. It operates in the Retail Trade industry. The enterprise was incorporated on May 17, 2021. Medikanuclear S.A. currently employs 8 (2024) people. In 2024, the company reported a net sales revenue drop of 13.51%. Its’ total assets recorded a growth of 16.19%. The enterprise’s net profit margin increased by 0.42% in 2024.

Headquarters
las Casas 650
Quito; Pichincha;

Contact Details: Purchase the Medikanuclear S.A. report to view the information.

Basic Information

Total Employees:

Purchase the Medikanuclear S.A. report to view the information.

Registered Capital:

Purchase the Medikanuclear S.A. report to view the information.

Financial Auditors:

Purchase the Medikanuclear S.A. report to view the information.

Incorporation Date:

May 17, 2021

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Medikanuclear S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

-13.51%▼

Total operating revenue

-13.51%▼

Operating profit (EBIT)

95.61%▲

EBITDA

117.87%▲

Net Profit (Loss) for the Period

95.61%▲

Total Assets

16.19%▲

Total Equity

134.72%▲

Operating Profit Margin (ROS)

0.42%▲

Net Profit Margin

0.42%▲

Return on Equity (ROE)

-1.21%▼

Quick Ratio

0.15%▲

Cash Ratio

0.01%▲

Similar companies

Related EMIS Industry Reports